← Companies
CorMedix Inc.
Data as of Oct 14, 2026
Reported federal lobbying
$1.4M
7 filings · latest Jul 31, 2026
Federal contracts since 2024
$0
2 awards · latest Sep 7, 2024
Lobbying
$1,400,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 31, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues$1.4M7 filings
Latest filings, Apr 2025 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 31, 2026 | CORMEDIX INC. Health Issues H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026 | $220,000 |
| Jul 2, 2026 | CORMEDIX INC. Health Issues H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026 | $380,000 |
| Feb 5, 2026 | CORMEDIX INC. Health Issues H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 6214/S. 2730, Kidney Care Access Protection Act | $150,000 |
| Oct 20, 2025 | CORMEDIX INC. Health Issues S. 2730, Kidney Care Access Protection Act H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention. | $150,000 |
| Jul 31, 2025 | CORMEDIX INC. Health Issues H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention. | $150,000 |
| Apr 21, 2025 | CORMEDIX INC. Health Issues H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention. | $200,000 |